Patents by Inventor Toshimitsu Kishimoto

Toshimitsu Kishimoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Neurotrophic factor expression-inducing agent
    Publication number: 20030186332
    Abstract: The culture supernatant of COS cells expressing the PSEC56 gene was found to have a neurite extension effect. The main substance of the activity contained in this culture supernatant was revealed to be NGF. It was shown that PSEC56 can be utilized as a neurotrophic factor expression-inducing agent, and that the NGF induction system can be utilized for drug development against diseases of the nervous system.
    Type: Application
    Filed: April 4, 2003
    Publication date: October 2, 2003
    Inventors: Cristina Mitsumori, Noriyuki Morikawa, Koji Hayashi, Kenji Nagahari, Toshio Ota, Yuri Hio, Tetsuo Nishikawa, Takao Isogai, Masakazu Kawasaki, Kenji Hashimoto, Toshimitsu Kishimoto
  • Novel guanosine triphosphate-binding protein-coupled receptors, genes thereof and production and use of the same
    Publication number: 20030157558
    Abstract: Nine novel genes sustaining hydrophobic domains, which are estimated to be seven transmembrane domains characteristic to G protein-coupled receptors, are successfully isolated by human tissue cDNA screening. These genes and proteins which are the expression products thereof are usable in screening ligands, screening agonists or antagonists which are useful as drugs, diagnosing diseases in which these gene participate, etc.
    Type: Application
    Filed: October 1, 2002
    Publication date: August 21, 2003
    Inventors: Shun-ichiro Matsumoto, Tamaki Oda, Youko Saito, Noriyuki Morikawa, Kenji Yoshida, Makiko Suwa, Tomoyasu Sugiyama, Toshimitsu Kishimoto, Kouji Kanzaki, Shin-ichiro Yasuda, Yoshihisa Inoue
  • Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
    Patent number: 5869450
    Abstract: Peptide analogues are provided with amino acid sequences of the corticotropin-releasing factor superfamily, but having at least one amino acid residue that has been replaced with a D-amino acid residue or a D-amino acid analog. The peptide analogues have anti-inflammatory activity while having a receptor selectivity and thus a disassociated ACTH response.
    Type: Grant
    Filed: March 6, 1996
    Date of Patent: February 9, 1999
    Assignee: The Regents of the University of California
    Inventors: Edward T. Wei, Holly A. Thomas, Toshimitsu Kishimoto